Literature DB >> 27347322

Involvement of microRNA-1297, a new regulator of HMGA1, in the regulation of glioma cell growth in vivo and in vitro.

Jiachong Wang1, Xiaoyun Xu2, Shaowei Mo2, Ye Tian3, Jian Wu4, Jianning Zhang3, Jiannong Zhao2.   

Abstract

MicroRNAs (miRNAs) are a class of versatile gene expression regulators, participating in the regulation of gene expression at the post-transcriptional level in both physiological and pathological conditions. Gliomas are the most common brain malignancy in adults, and deregulation of microRNAs takes part in the gliomagenesis process. Here, we found that the expression of miR-1297 is significantly reduced in both glioma cell lines and clinical glioma tissues. Using the MTT assay, soft agar colony formation assay and xenograft tumor formation assay, we show that miR-1297 is a tumor suppressor microRNA in gliomas. We demonstrate that the high mobility group protein A1 (HMGA1) is the functional target of miR-1297 in glioma cells. HMGA1 significantly promotes the growth of glioma cells both in vitro and in vivo. Together, we unveil a new molecular mechanism in gliomas that may shed new light on understanding this brain malignancy.

Entities:  

Keywords:  HMGA1; cell growth; glioma; miR-1297

Year:  2016        PMID: 27347322      PMCID: PMC4891427     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  30 in total

1.  MiR-1297 promotes apoptosis and inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting HMGA2.

Authors:  Yu Liu; Hongyan Liang; Xiaofeng Jiang
Journal:  Int J Mol Med       Date:  2015-09-10       Impact factor: 4.101

Review 2.  Molecular mechanism of HMGA1 deregulation in human neuroblastoma.

Authors:  Giuseppe Giannini; Fabio Cerignoli; Massimiliano Mellone; Isabella Massimi; Cinzia Ambrosi; Christian Rinaldi; Alberto Gulino
Journal:  Cancer Lett       Date:  2005-10-18       Impact factor: 8.679

3.  Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study.

Authors:  Otto Visser; Eva Ardanaz; Laura Botta; Milena Sant; Andrea Tavilla; Pamela Minicozzi
Journal:  Eur J Cancer       Date:  2015-09-26       Impact factor: 9.162

4.  Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.

Authors:  Stuart A Grossman; Xiaobu Ye; Steven Piantadosi; Serena Desideri; Louis B Nabors; Myrna Rosenfeld; Joy Fisher
Journal:  Clin Cancer Res       Date:  2010-04-06       Impact factor: 12.531

5.  MiR-1297 regulates the growth, migration and invasion of colorectal cancer cells by targeting cyclo-oxygenase-2.

Authors:  Pu Chen; Bei-Li Wang; Bai-Shen Pan; Wei Guo
Journal:  Asian Pac J Cancer Prev       Date:  2014

Review 6.  Malignant astrocytic glioma: genetics, biology, and paths to treatment.

Authors:  Frank B Furnari; Tim Fenton; Robert M Bachoo; Akitake Mukasa; Jayne M Stommel; Alexander Stegh; William C Hahn; Keith L Ligon; David N Louis; Cameron Brennan; Lynda Chin; Ronald A DePinho; Webster K Cavenee
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

Review 7.  MicroRNAs in human glioblastoma: from bench to beside.

Authors:  Hongxiang Wang; Tao Xu; Ying Jiang; Yong Yan; Rong Qin; Juxiang Chen
Journal:  Front Biosci (Landmark Ed)       Date:  2015-01-01

Review 8.  RNA-Mediated Regulation of HMGA1 Function.

Authors:  Arndt G Benecke; Sebastian Eilebrecht
Journal:  Biomolecules       Date:  2015

Review 9.  High mobility group a proteins as tumor markers.

Authors:  Pierlorenzo Pallante; Romina Sepe; Francesca Puca; Alfredo Fusco
Journal:  Front Med (Lausanne)       Date:  2015-03-25

10.  miR-132 can inhibit glioma cells invasion and migration by target MMP16 in vitro.

Authors:  Hangzhou Wang; Xue-Tao Li; Chun Wu; Zhi-Wu Wu; Yan-Yan Li; Tian-Quan Yang; Gui-Lin Chen; Xue-Shun Xie; Yu-Lun Huang; Zi-Wei Du; You-Xin Zhou
Journal:  Onco Targets Ther       Date:  2015-11-03       Impact factor: 4.147

View more
  15 in total

1.  miR-1297 regulates neural stem cell differentiation and viability through controlling Hes1 expression.

Authors:  Jiaolin Zheng; Dan Yi; Xiaodong Shi; Huaizhang Shi
Journal:  Cell Prolif       Date:  2017-05-02       Impact factor: 6.831

2.  Regulatory Network of PD1 Signaling Is Associated with Prognosis in Glioblastoma Multiforme.

Authors:  Camila M Lopes-Ramos; Tatiana Belova; Tess H Brunner; Marouen Ben Guebila; Daniel Osorio; John Quackenbush; Marieke L Kuijjer
Journal:  Cancer Res       Date:  2021-09-07       Impact factor: 12.701

3.  miR-1297 inhibits osteosarcoma cell proliferation and growth by targeting CCND2.

Authors:  Pan Jiang; Lianghao Mao; Xuan Lei; Chunshan Luo; Yiming Zhang; Xinyu Zhong; Zhenyu Yin; Xiaofeng Xu; Dapeng Li; Qiping Zheng
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

Review 4.  High Mobility Group A1 (HMGA1): Structure, Biological Function, and Therapeutic Potential.

Authors:  Lu Wang; Ji Zhang; Min Xia; Chang Liu; Xuyu Zu; Jing Zhong
Journal:  Int J Biol Sci       Date:  2022-07-04       Impact factor: 10.750

5.  MiR-1297 negatively regulates metabolic reprogramming in glioblastoma via repressing KPNA2.

Authors:  Huibing Li; Honggang Yuan
Journal:  Hum Cell       Date:  2020-03-02       Impact factor: 4.174

6.  Serum microRNAs are non-invasive biomarkers for the presence and progression of subarachnoid haemorrhage.

Authors:  Nian-Sheng Lai; Jia-Qi Zhang; Fei-Yun Qin; Bin Sheng; Xing-Gen Fang; Zhen-Bao Li
Journal:  Biosci Rep       Date:  2017-02-23       Impact factor: 3.840

7.  Ras suppressor-1 (RSU-1) promotes cell invasion in aggressive glioma cells and inhibits it in non-aggressive cells through STAT6 phospho-regulation.

Authors:  Maria Louca; Andreas Stylianou; Angeliki Minia; Vaia Pliaka; Leonidas G Alexopoulos; Vasiliki Gkretsi; Triantafyllos Stylianopoulos
Journal:  Sci Rep       Date:  2019-05-23       Impact factor: 4.379

8.  LncRNA TTN-AS1 acts as a tumor promoter in gallbladder carcinoma by regulating miR-107/HMGA1 axis.

Authors:  Zhaoxia Lin; Yaosheng Li; Rongfeng Shao; Yuqing Hu; Han Gao
Journal:  World J Surg Oncol       Date:  2021-06-05       Impact factor: 2.754

9.  Early serum miR-1297 is an indicator of poor neurological outcome in patients with aSAH.

Authors:  Bin Sheng; Nian-Sheng Lai; Yang Yao; Jin Dong; Zhen-Bao Li; Xin-Tong Zhao; Jia-Qiang Liu; Xue-Qin Li; Xing-Gen Fang
Journal:  Biosci Rep       Date:  2018-11-20       Impact factor: 3.840

10.  Circ_CLIP2 promotes glioma progression through targeting the miR-195-5p/HMGB3 axis.

Authors:  Bing Xiao; Shi-Gang Lv; Miao-Jing Wu; Xiao-Li Shen; Wei Tu; Min-Hua Ye; Xin-Gen Zhu
Journal:  J Neurooncol       Date:  2021-08-06       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.